Main Menu
Education
The Lancet and the Lancet series of journals
| 2017 Jan 14 - Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: a post-hoc efficacy analysis of the START study |
| 2017 Jan 21 - Lung cancer: current therapies and new targeted treatments |
| 2017 Jan 27 - Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial |
| 2016 Oct 19 - Lung volume reduction for emphysema |
| 2016 May 6 - Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial |
| 2016 May 6 - Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial |
| 2016 May 6 - Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial |
| 2016 Feb 23 - The transmission of Mycobacterium tuberculosis in high burden settings |
| 2016 Feb 23 - Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study |
| 2016 Feb 23 - Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial |
Page 3 of 33
